✦ LIBER ✦

Sensor-Augmented Insulin Pump Therapy: Results of the First Randomized Treat-to-Target Study

✍ Scribed by Hirsch, Irl B.; Abelseth, Jill; Bode, Bruce W.; Fischer, Jerome S.; Kaufman, Francine R.; Mastrototaro, John; Parkin, Christopher G.; Wolpert, Howard A.; Buckingham, Bruce A.

Book ID: 115460463
Publisher: Mary Ann Liebert
Year: 2008
Tongue: English
Weight: 150 KB
Volume: 10
Category: Article
ISSN: 1520-9156
DOI: 10.1089/dia.2008.0068

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sensor augmented pump therapy from onset

Sensor augmented pump therapy from onset of type 1 diabetes: late follow-up results of the Pediatric Onset Study

✍ Olga Kordonouri; Reinhard Hartmann; Ewa Pankowska; Birgit Rami; Thomas Kapellen; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB

Sensor-augmented pump therapy from the d

Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12

✍ O. Kordonouri; E. Pankowska; B. Rami; T. Kapellen; R. Coutant; R. Hartmann; K. L 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 155 KB

Participants’ experiences of intensifyin

Participants’ experiences of intensifying insulin therapy during the Treating to Target in Type 2 Diabetes (4-T) trial: qualitative interview study

✍ N. Jenkins; N. Hallowell; A. J. Farmer; R. R. Holman; J. Lawton 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB

Addition of pioglitazone to stable insul

Addition of pioglitazone to stable insulin therapy in patients with poorly controlled type 2 diabetes: results of a double-blind, multicentre, randomized study

✍ J. A. Davidson; A. Perez; J. Zhang; The Pioglitazone 343 Study Group 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

PDB54 COMPARISON OF TREATMENT COSTS BETW

PDB54 COMPARISON OF TREATMENT COSTS BETWEEN BASAL-SUPPORTED ORAL THERAPY (BOT) WITH INSULIN GLARGINE (GLA) AND BOT WITH INSULIN DETEMIR (DET) IN PATIENTS WITH TYPE 2 DIABETES (T2D): ECONOMIC EVALUATION BASED ON THE RESULTS OF THE INSULIN GLARGINE (LANTUS®) VERSUS INSULIN DETEMIR (LEVEMIR®) TREAT-TO-TARGET (L2T3) STUDY

✍ PK Schädlich; KC Koltermann; FW Dippel; EG Hagenmeyer; B Häussler 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Anastrozole (‘Arimidex’) versus tamoxife

Anastrozole (‘Arimidex’) versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: Results of the double-blind cross-over SAKK trial 21/95 - a sub-study of the TARGET (Tamoxifen or ‘Arimidex’ Randomized Group Efficacy and Tolerability) trial

✍ Beat Thürlimann; Dagmar Hess; Dieter Köberle; Isabella Senn; Pierluigi Ballabeni 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 348 KB